Primrose Bio, Inc.
Primrose Bio specializes in innovative manufacturing solutions for biotherapeutics and vaccines, setting new standards for quality and production efficiency.
Funding history
About Primrose Bio, Inc.
How much funding has Primrose Bio, Inc. raised?
Primrose Bio, Inc. has raised $15.0M in total funding. The most recent round was Series B.
Where is Primrose Bio, Inc. headquartered?
Primrose Bio, Inc. is headquartered in San Diego, CA.
What does Primrose Bio, Inc. do?
Primrose Bio specializes in innovative manufacturing solutions for biotherapeutics and vaccines, setting new standards for quality and production efficiency.
What problem does Primrose Bio, Inc. solve?
Manufacturing is described as a bottleneck where biotherapeutic and vaccine breakthroughs can stall.
What's Primrose Bio, Inc.'s solution?
Primrose Bio provides strain engineering for protein production (via its Pfenex Expression Technology), catalog and custom RNA polymerases for mRNA manufacturing, and CRM197 carrier protein for conjugate vaccine programs.
What makes Primrose Bio, Inc. different?
The company highlights its proprietary Pfenex Expression Technology, RNA polymerases optimized for consistent and scalable mRNA manufacturing, and a regulatory-friendly, high-purity CRM197 product.
What makes Primrose Bio, Inc. notable?
Primrose Bio has raised about $16.7M for next-generation therapeutics manufacturing, with backing from the NIH's NCATS and the National Science Foundation alongside investors like 1315 Capital.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.